Neuropsychiatry Drug Sensitivity Panel
Definition
A panel that jointly evaluates the genes associated with the metabolism of and response to antidepressants, antipsychotics and anxiolytics (CYP2D6, CYP2C19, CYP1A2, SLC6A4/5-HTTLPR, HLA-A31:01/HLA-B15:02). In 2023 CPIC published CYP2D6/CYP2C19-based dosing guidance for SSRIs.
Gene/region examined
CYP2D6, CYP2C9, CYP2C19, CYP1A2
Method
Mini Sequencing
Accepted sample types
Peripheral blood (EDTA)
Inheritance
Germline/inherited.